SCHEMBL2558812

SCHEMBL2558812

CC(C)C(O)(CCN(C)C)c1cccc(O)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.45
CHRNB2 P17787 1/20 0.42
CHRNA4 P43681 1/20 0.42
OPRM1 P35372 5/20 0.38
OPRK1 P41145 2/20 0.38
SLC22A1 O15245 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
ADRA1A P35348 1/20 0.38
KCNH2 Q12809 1/20 0.38
DRD3 P35462 3/20 0.38
DRD2 P14416 2/20 0.38
DRD4 P21917 2/20 0.38
CYP2D6 P10635 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
LMNA P02545 1/20 0.37
OPRD1 P41143 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2554080 1.00 SMN1; SMN2 (0.45) SMN1; SMN2CHRNB2CHRNA4OPRM1OPRK1
SCHEMBL670608 0.81 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1
SCHEMBL669922 0.81 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1
SCHEMBL670046 0.81 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL670045 0.80 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL16742846 0.80 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1
SCHEMBL15109995 0.78 BCL2 (0.55) SMN1; SMN2
SCHEMBL3899366 0.75 ALDH1A1 (0.50) CHRNB2CHRNA4OPRM1OPRK1SLC22A1
SCHEMBL174568 0.75 ALDH1A1 (0.50) CHRNB2CHRNA4OPRM1OPRK1SLC22A1
SCHEMBL4495715 0.75 ALDH1A1 (0.50) CHRNB2CHRNA4OPRM1OPRK1SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2556048-A2 NOVEL PROCESS FOR PREPARING HIGHLY PURE TAPENTADOL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Actavis Group PTC EHF (IS) 2013-02-13 EP disclosed
WO-2011128784-A2 NOVEL PROCESS FOR PREPARING HIGHLY PURE TAPENTADOL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF ACTAVIS GROUP PTC EHF (IS) 2011-10-20 WO disclosed